- Home
- FCCO vs TLSA Comparison
FCCO vs TLSA Comparison
Compare FCCO & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCCO
- TLSA
- Stock Information
- Founded
- FCCO 1994
- TLSA 2013
- Country
- FCCO United States
- TLSA United Kingdom
- Employees
- FCCO N/A
- TLSA N/A
- Industry
- FCCO Major Banks
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- FCCO Finance
- TLSA Health Care
- Exchange
- FCCO Nasdaq
- TLSA Nasdaq
- Market Cap
- FCCO 190.8M
- TLSA 187.0M
- IPO Year
- FCCO 1998
- TLSA 2000
- Fundamental
- Price
- FCCO $28.41
- TLSA $1.66
- Analyst Decision
- FCCO Strong Buy
- TLSA
- Analyst Count
- FCCO 2
- TLSA 0
- Target Price
- FCCO $30.00
- TLSA N/A
- AVG Volume (30 Days)
- FCCO 23.2K
- TLSA 325.5K
- Earning Date
- FCCO 10-22-2025
- TLSA 05-06-2025
- Dividend Yield
- FCCO 2.24%
- TLSA N/A
- EPS Growth
- FCCO 57.01
- TLSA N/A
- EPS
- FCCO 2.23
- TLSA N/A
- Revenue
- FCCO $71,913,000.00
- TLSA N/A
- Revenue This Year
- FCCO $21.83
- TLSA N/A
- Revenue Next Year
- FCCO $28.41
- TLSA N/A
- P/E Ratio
- FCCO $12.80
- TLSA N/A
- Revenue Growth
- FCCO 21.39
- TLSA N/A
- 52 Week Low
- FCCO $19.46
- TLSA $0.63
- 52 Week High
- FCCO $28.85
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- FCCO 75.44
- TLSA 43.10
- Support Level
- FCCO $27.84
- TLSA $1.63
- Resistance Level
- FCCO $28.77
- TLSA $1.88
- Average True Range (ATR)
- FCCO 0.43
- TLSA 0.15
- MACD
- FCCO 0.02
- TLSA -0.01
- Stochastic Oscillator
- FCCO 76.00
- TLSA 38.46
About FCCO First Community Corporation
First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are; Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.